Bath & Body Works price target lowered to $43 from $44 at Goldman Sachs

Goldman Sachs lowered the firm’s price target on Bath & Body Works to $43 from $44 and keeps a Buy rating on the shares. The company’s solid 1Q results were likely overshadowed by guidance coming in below expectations, though today’s 6% decline in the stock price “seems overdone” as the firm’s FY25 EPS estimate is only moving down by about 3%, the analyst tells investors in a research note.